Zenshine’s drug discovery and development programs involve targeting purinergic signaling in immune cells and intracellular signal transduction pathways to modulate tumor microenvironment and thus to promote immunity. Oncology - targeting cancer intrinsic and extrinsic characteristics by either directly blocking tumor growth or modulating tumor microenvironment. Anti-infection - targeting pathogen infection that threats public health.
View More